Page last updated: 2024-08-23

alovudine and Carcinoma, Ductal, Breast

alovudine has been researched along with Carcinoma, Ductal, Breast in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujiwara, Y; Hamada, A; Hashimoto, J; Kanayama, Y; Kodaira, M; Kurihara, H; Miyakita, Y; Shimizu, C; Tamura, K; Tani, H; Watanabe, Y; Yamamoto, H; Yonemori, K; Yoshida, M; Yunokawa, M1
Boin, C; Bousquet, G; Cuvier, C; EspiƩ, M; Giacchetti, S; Groheux, D; HindiƩ, E; Misset, JL; Moretti, JL; Teyton, P1

Reviews

2 review(s) available for alovudine and Carcinoma, Ductal, Breast

ArticleYear
Molecular imaging using PET for breast cancer.
    Breast cancer (Tokyo, Japan), 2016, Volume: 23, Issue:1

    Topics: Bevacizumab; Breast Neoplasms; Carcinoma, Ductal, Breast; Cetuximab; Dideoxynucleosides; ErbB Receptors; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Norprogesterones; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, Progesterone; Receptors, Vascular Endothelial Growth Factor; Trastuzumab

2016
[PET/CT in breast cancer: an update].
    Bulletin du cancer, 2009, Volume: 96, Issue:11

    Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Dideoxynucleosides; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Treatment Outcome

2009